ELIZABETH HIJONA MURUAMENDIARAZ-rekin lankidetzan egindako argitalpenak (10)
2019
-
Pterostilbene reduces liver steatosis and modifies hepatic fatty acid profile in obese rats
Nutrients, Vol. 11, Núm. 5
2018
-
The dietary antioxidant piceatannol inhibits adipogenesis of human adipose mesenchymal stem cells and limits glucose transport and lipogenic activities in adipocytes
International Journal of Molecular Sciences, Vol. 19, Núm. 7
2017
-
Pterostilbene-induced changes in gut microbiota composition in relation to obesity
Molecular Nutrition and Food Research, Vol. 61, Núm. 1
2016
-
Effects of pterostilbene in brown adipose tissue from obese rats
Journal of Physiology and Biochemistry, Vol. 73, Núm. 3, pp. 457-464
-
Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects
Journal of Physiology and Biochemistry, Vol. 72, Núm. 3, pp. 567-582
-
Potential renoprotective effects of piceatannol in ameliorating the early-stage nephropathy associated with obesity in obese Zucker rats
Journal of Physiology and Biochemistry, Vol. 72, Núm. 3, pp. 555-566
2014
-
Effects of resveratrol and other polyphenols in hepatic steatosis
World Journal of Gastroenterology, Vol. 20, Núm. 23, pp. 7366-7380
-
Novel equation to determine the hepatic triglyceride concentration in humans by MRI: Diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery
BMC Medicine, Vol. 12, Núm. 1
2013
-
Several statins increase body and liver fat accumulation in a model of metabolic syndrome
Journal of Physiology and Pharmacology, Vol. 64, Núm. 3
2012
-
Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress
British Journal of Nutrition, Vol. 107, Núm. 2, pp. 202-210